OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Arshi Khanam, Paul Saleeb, Shyam Kottilil
Cells (2021) Vol. 10, Iss. 5, pp. 1097-1097
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells
Hikmet Akkız, Robert K. Gieseler, Ali Canbay
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7873-7873
Open Access | Times Cited: 15

Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
Arshi Khanam, Joel V. Chua, Shyam Kottilil
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5497-5497
Open Access | Times Cited: 87

Cholesterol-Mediated Seeding of Protein Corona on DNA Nanostructures for Targeted Delivery of Oligonucleotide Therapeutics to Treat Liver Fibrosis
Kyoung‐Ran Kim, Jung-Hyun Kim, Ji Hyun Back, et al.
ACS Nano (2022) Vol. 16, Iss. 5, pp. 7331-7343
Closed Access | Times Cited: 37

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
Yuanquan Zhao, Xiwen Deng, Guo-Qi Xu, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 22

Kaempferol attenuates carbon tetrachloride (CCl4)-induced hepatic fibrosis by promoting ASIC1a degradation and suppression of the ASIC1a-mediated ERS
Rui Cao, Chun Cao, Xiaojie Hu, et al.
Phytomedicine (2023) Vol. 121, pp. 155125-155125
Closed Access | Times Cited: 22

The Role of Exosomes in Inflammatory Diseases and Tumor-Related Inflammation
Yuan Tian, Cheng Cheng, Yuchong Wei, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 1005-1005
Open Access | Times Cited: 36

Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
Sandra Torres, Paula Segalés, Carmen García‐Ruiz, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1475-1475
Open Access | Times Cited: 34

Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
Anshika Jangra, Ashish Kothari, Phulen Sarma, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1500-1500
Open Access | Times Cited: 31

Protective Effect of Polyphenols, Protein, Peptides, and Polysaccharides on Alcoholic Liver Disease: A Review of Research Status and Molecular Mechanisms
Wan Wang, Cong Xu, Qingyun Wang, et al.
Journal of Agricultural and Food Chemistry (2023)
Closed Access | Times Cited: 18

Liver Fibrosis: From Basic Science to Clinical Progress
Hikmet Akkız, Robert K. Gieseler, Ali Canbay
(2024)
Open Access | Times Cited: 6

A novel pectin-like polysaccharide from Crocus sativus targets Galectin-3 to inhibit hepatic stellate cells activation and liver fibrosis
Bixi Tang, Can Jin, Maoting Li, et al.
Carbohydrate Polymers (2024) Vol. 348, pp. 122826-122826
Closed Access | Times Cited: 6

Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy
Liyue Zhou, Qiangwei Liang, Yifan Li, et al.
Acta Biomaterialia (2022) Vol. 152, pp. 235-254
Closed Access | Times Cited: 24

The Material World of 3D‐Bioprinted and Microfluidic‐Chip Models of Human Liver Fibrosis
Ana Margarida Carvalho, Ruchi Bansal, Cristina C. Barrias, et al.
Advanced Materials (2023) Vol. 36, Iss. 2
Open Access | Times Cited: 12

Adipose Tissue and Umbilical Cord Tissue: Potential Sources of Mesenchymal Stem Cells for Liver Fibrosis Treatment
Hafiz Ghufran, Maryam Azam, Azra Mehmood, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 14, Iss. 4, pp. 101364-101364
Closed Access | Times Cited: 4

Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives
Janitha M. Unagolla, Subarna Das, Riley Flanagan, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124381-124381
Closed Access | Times Cited: 4

Histological Indicators of Aging at the Cellular Level: Cellular Senescence, Fibrosis, and Regenerative Capacity
Eman Ali Elkordy
Journal of Microscopy and Ultrastructure (2025)
Closed Access

Recent advances in small molecule design strategies against hepatic fibrosis
Heming Chen, Wei Su, Tingting Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117281-117281
Closed Access

miR-372-3p represses hepatic stellate cell activation via the RhoC/ROCK pathway
Shiyu Ou, Xiaoling Tang, Zhongzhuan Li, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access

Shear Wave Dispersion in Chronic Liver Disease: From Physical Principles to Clinical Usefulness
Matteo Garcovich, Mattia Paratore, Maria Elena Ainora, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 6, pp. 945-945
Open Access | Times Cited: 11

Apigenin intervenes in liver fibrosis by regulating PKM2-HIF-1α mediated oxidative stress
Tao Sun, Saifei Li, M Kellis, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 721, pp. 150130-150130
Closed Access | Times Cited: 3

Pharmacokinetics and anti-liver fibrosis characteristics of amygdalin: Key role of the deglycosylated metabolite prunasin
Congcong Zhang, Dingqi Zhang, Yongli Wang, et al.
Phytomedicine (2022) Vol. 99, pp. 154018-154018
Closed Access | Times Cited: 18

Page 1 - Next Page

Scroll to top